This bid is closed — responses were due August 6, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid is for a study to evaluate the in vivo efficacy of Fc-bispecifics, likely involving animal models, for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as part of NIH's biomedical research functions.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
In vivo efficacy study of Fc-bispecifics (research services)
1
lot
$150,000.00
$150,000.00
Professional Services
Estimated Bid Value
$150,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds the 1 document, contracting-officer contacts and AI response outlines.